Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

All GLG News Analyses Filed Under: Business of Medicine

Articles with lock require a GLG News subscription
Posted April 14, 2008
Another nail in the coffin
Analysis of: Pfizer Statement on Exubera Labeling Update in the United States | pharmalive.com
Author: GLG Member Program Contributor
Exubera is long longer being promoted by Pfizer. The drug id dead. The bigger question will be the safety of any inhaled insulin that will try to come to market.
Posted April 14, 2008
Should not be a driving force
Analysis of: Will Insurers Reduce Coverage For Vytorin? | www.pharmalot.com
Author: GLG Member Program Contributor
Physicians themselves with pt request will likely be the driving force in the decrease use of Vytorin till this issue is settled. This in turn will likely change coverage patterns.
Posted April 14, 2008
FDA Analysis of Singulair- Wait until the evidence is in.
Analysis of: FDA investigates suicide with Merck drug | www.physorg.com
Author: GLG Member Program Contributor
The FDA is investigating Merck's Singulair for a possible link to suicidal thought and action.  With over 28 million prescriptions last year and a 12 year record of safety in children and adults, the evidence must be evaluated closely before coming to any conclusion. Of note antihistamines, including...
Posted April 14, 2008
Hospitalized Children at 450% Greater Risk of Harmful Medication Errors than Thought
Analysis of: Medical Errors Threatan One in 15 Hospitalized Children | www.healthcareitnews.com
Author: GLG Member Program Contributor
In the latest study released on Monday (April 7) in the journal "Pediatrics", researchers found a rate of 11 drug-related harmful events for every 100 hospitalized children.  That new number compares with an earlier estimate of only two per 100 hospitalized children based on traditional...
Posted April 11, 2008
Second anda half line drug
Analysis of: The Vytorin Saga Continues: Krumholz Strikes Back | www.pharmalot.com
Author: GLG Member Program Contributor
The treatment of hyperlipidemia has profound repercussions on cardiovascular disease. The market is huge. I hear that there were 35 million prescriptions for ezetimibe products last year. Although the epidemiological association between LDL and cardiac risk is strong, LDL is an imperfect surrogate for...
Posted April 10, 2008
Millennium purchase may open up avenues for more sales??
Analysis of: Takeda to Buy Millennium In $8.8 Billion Deal | online.wsj.com
Author: GLG Member Program Contributor
Japan's biggest (by revenue) drug manufacturer has placed a bid For Millennium and it's primary product Velcade.
Posted April 9, 2008
Losses Loom in Pensulvania if Poltics Guides Health Insurance Absent
Analysis of: House OKs Limits on Health Insurance | www.post-gazette.com
Author: GLG Member Program Contributor
Pennsylvania is a bell weather for hospital reporting in the US.  The "hospital costing containment council" (I forget the name) is famous for highlighting percentage of patients acquiring hospital infections after arrival.  Accountability for these very high costs lay with people managing...
Posted April 8, 2008
Vytorin resolution not soon
Analysis of: The Vytorin Saga Continues: Krumholz Strikes Back | www.pharmalot.com
Author: GLG Member Program Contributor
Development of plaque in arteries takes place over a lifetime.  There have been studies suggesting plaque removal can happen over shorter periods, but data demonstration that this solves medical problems is not available.  Complicatons like heart attacks come from the unstable plaque...
Posted April 8, 2008
Bigger is not always better
Analysis of: Investor chief questions role of Big Pharma in development of medicines | business.timesonline.co.uk
Author: GLG Member Program Contributor
Larger R&D is important to developing products which have large capital requirements and need for large groups.  Smaller groups can act much faster when developing products with managable resouce needs.  Smaller groups working independently from a large corporation have several...
Posted April 8, 2008
Apocalypse Now: Physicians and Insurers Agree on Performance Measurement Principles
Analysis of: Consumers, Health Care Purchasers, Physicians, and Health Insurers Announce Agreement on Principles to Guide Physician Performance Reporting | www.cyperus.com
Author: GLG Member Program Contributor
Leading consumer, employer and labor organizations have agreed with the top medical and health insurance groups on principles to govern the development of physician performance measures.  The "Patient Charter for Physician Performance Measurement, Reporting and Tiering Programs" creates a national...
Previous Page : 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 Next261 to 270 of 648

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-05T01:45:24.617